These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6757514)

  • 1. [Tuberculosis prevention by BCG vaccine].
    Hashimoto T
    Kekkaku; 1982 Jun; 57(6):329-34. PubMed ID: 6757514
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental study of BCG-M vaccine with a lowered antigen dose].
    Iablokova TB; Pisarenko NN; Levi DT; Kazachkova TE; Nesterenko LA
    Probl Tuberk; 1985; (6):52-5. PubMed ID: 3900992
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quarter of a century in the field of BCG.
    Rodopska S
    Dev Biol Stand; 1986; 58 ( Pt A)():257-72. PubMed ID: 3297865
    [No Abstract]   [Full Text] [Related]  

  • 7. The success and failure of BCG - implications for a novel tuberculosis vaccine.
    Andersen P; Doherty TM
    Nat Rev Microbiol; 2005 Aug; 3(8):656-62. PubMed ID: 16012514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tuberculosis in childhood - retrospective and prospective view (100 years since the discovery of the tubercle bacillus by Robert Koch)].
    Weingärtner L
    Padiatr Grenzgeb; 1982; 21(2):113-26. PubMed ID: 6810279
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic methods of postvaccinal complications after administration of BCG vaccine].
    Zwolska Z; Augustynowicz-Kopeć E; Zabost A; Ziołkowski J; Buchwald J; Płończak M; Walas W; Ziebiński M
    Przegl Epidemiol; 2004; 58 Suppl 1():123-8. PubMed ID: 15807170
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species.
    Murphy D; Corner LA; Gormley E
    Tuberculosis (Edinb); 2008 Jul; 88(4):344-57. PubMed ID: 18222731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraduodenal vaccination of brushtail possums with bacille Calmette-Guérin enhances immune responses and protection against Mycobacterium bovis infection.
    Buddle BM; Aldwell FE; Keen DL; Parlane NA; Yates G; de Lisle GW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):377-83. PubMed ID: 9432396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A plea for the use of BCG vaccine against tuberculosis in the United States.
    Rosenthal SR
    Med Times; 1978 Jul; 106(7):2d (88)-(88)-7d. PubMed ID: 353438
    [No Abstract]   [Full Text] [Related]  

  • 16. [BCG: symposium].
    Takase Y; Kayaba K; Kobayashi T; Horai Z; Yokoi M
    Kekkaku; 1970 Nov; 45(11):390-2. PubMed ID: 4924414
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of tuberculosis by BCG (AUTHOR'S TRANSLATION)].
    Toppet M; Hofman B; Dab I; Dachy A
    Acta Tuberc Pneumol Belg; 1976; 67(3-4):207-17. PubMed ID: 1016527
    [No Abstract]   [Full Text] [Related]  

  • 18. [Caseation of lymph nodes in infants after intracutaneous vaccination with original French BCG vaccine].
    Zapaśnik-Kobierska MH; Buraczewska M; Rajtar-Leontiew Z
    Pediatr Pol; 1970 Aug; 45(8):923-8. PubMed ID: 4918878
    [No Abstract]   [Full Text] [Related]  

  • 19. CDC issues recommendations on the role of BCG vaccine in the prevention and control of tuberculosis.
    Am Fam Physician; 1996 Sep; 54(3):1115-8. PubMed ID: 8784176
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies of 5 G substrains. II. Tuberculin sensitization with 5 BCG vaccines].
    Paraschivesco M; Gheorghiu M; Petrovici-Venson E
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):541-4. PubMed ID: 4923822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.